XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.3
Note 17 - Earnings Per Share
3 Months Ended
Sep. 30, 2024
Notes to Financial Statements  
Earnings Per Share [Text Block]

Note 17 - Earnings Per Share

 

Basic net income (loss) per share is calculated by dividing the net income (loss) available to the common stockholders by the weighted average number of common shares outstanding during that period. Diluted net income (loss) per share reflects the potential of securities that could share in the net income (loss) of the Company. For the three months ended September 30, 2023, the Company incurred a net loss from continuing operations and discontinued operations and thus did not include common equivalent shares in the computation of diluted net loss per share because the effect would have been anti-dilutive.

 

Basic net income or loss per common share is calculated by dividing net income or loss available to common stockholders by the basic weighted-average number of common shares outstanding for the respective period. Diluted net income or loss per common share is calculated by dividing adjusted net income or loss by the diluted weighted-average number of common shares outstanding, which includes the effect of potentially dilutive securities. Potentially dilutive securities for this calculation consist of warrants to purchase common stock that are either liability classified or equity classified (see Note 16 – Warrants); employee stock options (see Note 15 – Equity Incentive Plans); employee unvested restricted stock (see Note 15 – Equity Incentive Plans); and employee unvested restricted stock units (see Note 15 – Equity Incentive Plans). For the three months ended September 30, 2024, and 2023, if the Company incurred a net loss from continuing operations; a net loss from discontinued operations, net of tax; or a net loss then the Company did not include common equivalent shares in the computation of diluted net loss from continuing operations per share; diluted net loss from discontinued operations, net of tax; or diluted net loss per share because the effect would have been anti-dilutive.

 

The following is a reconciliation of the numerator and the denominator used in the basic per share calculations:

 

  

Three Months Ended

 
  

September 30,

 
  

2024

  

2023

 
  

(in thousands, except share and per share data)

 

BASIC

        

Numerators:

        

Net income (loss) from continuing operations

 $1,093  $(7,473)

Net income (loss) from discontinued operations, net of tax

  381   (647)

Net income (loss)

 $1,474  $(8,120)

Denominator:

        

Basic weighted-average common shares outstanding

  6,068,019   5,482,037 

Per share calculations:

        

Net income (loss) per share from continuing operations

 $0.18  $(1.36)

Net income (loss) per share from discontinued operations, net of tax

 $0.06  $(0.12)

Net income (loss) per share

 $0.24  $(1.48)

 

The following is a reconciliation of the numerator and the denominator used in the diluted per share calculations:

 

  

Three Months Ended

 
  

September 30,

 
  

2024

  

2023

 
  

(in thousands, except share and per share data)

 

DILUTED: CONTINUING OPERATIONS

        

Numerator:

        

Net income (loss) from continuing operations

 $1,093  $(7,473)

Adjustment for change in fair value of warrant liabilities

  (2,880)   

Adjusted numerator - net loss from continuing operations

 $(1,787) $(7,473)

Denominator:

        

Basic weighted-average common shares outstanding

  6,068,019   5,482,037 

Dilutive effect of warrants to purchase common stock

  3,028,862    

Dilutive effect of unvested restricted stock and restricted stock units

  2,720    

Diluted weighted-average common shares outstanding

  9,099,601   5,482,037 

Per share calculation:

        

Net loss per share from continuing operations

 $(0.20) $(1.36)
         

DILUTED: DISCONTINUED OPERATIONS

        

Numerator:

        

Net income (loss) from discontinued operations, net of tax

 $381  $(647)

Denominator:

        

Basic weighted-average common shares outstanding

  6,068,019   5,482,037 

Dilutive effect of warrants to purchase common stock

  3,028,862    

Dilutive effect of unvested restricted stock and restricted stock units

  2,720    

Diluted weighted-average common shares outstanding

  9,099,601   5,482,037 

Per share calculation:

        

Net income (loss) per share from discontinued operations, net of tax

 $0.04  $(0.12)
         

DILUTED: NET INCOME (LOSS)

        

Numerator:

        

Net income (loss)

 $1,474  $(8,120)

Adjustment for change in fair value of warrant liabilities

  (2,880)   

Adjusted numerator - net loss

 $(1,406) $(8,120)

Denominator:

        

Basic weighted-average common shares outstanding

  6,068,019   5,482,037 

Dilutive effect of warrants to purchase common stock

  3,028,862    

Dilutive effect of unvested restricted stock and restricted stock units

  2,720    

Diluted weighted-average common shares outstanding

  9,099,601   5,482,037 

Per share calculation:

        

Net loss per share

 $(0.15) $(1.48)

 

The following table sets forth securities that could be considered anti-dilutive, and therefore are excluded from the calculation of diluted weighted-average common shares outstanding and related per share calculations:

 

  

Three Months Ended

 
  

September 30,

 
  

2024

  

2023

 

Warrants to purchase common stock - liability classified (note 16)

  455,392   6,498,980 

Warrants to purchase common stock - equity classified (note 16)

  18,114   39,072 

Employee unvested restricted stock (note 15)

  10,644   46,656 

Employee unvested restricted stock units (note 15)

  1,211   3,463 

Employee stock options (note 15)

  141,439   162,683 

Total anti-dilutive securities

  626,800   6,750,854